These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11121058)

  • 41. Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml.
    Kupfer B; Matz B; Däumer MP; Roden F; Rockstroh JK; Qurishi N; Spengler U; Kaiser R
    J Med Virol; 2007 Oct; 79(10):1440-5. PubMed ID: 17705170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.
    Sevilya Z; Chorin E; Gal-Garber O; Zelinger E; Turner D; Avidor B; Berke G; Hassin D
    Front Immunol; 2018; 9():2068. PubMed ID: 30254642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
    Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
    J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.
    Johnson RP; Trocha A; Buchanan TM; Walker BD
    J Virol; 1993 Jan; 67(1):438-45. PubMed ID: 7677956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Germinal centers B-cell reaction and T follicular helper cells in response to HIV-1 infection.
    Jeger-Madiot R; Heredia M; Graff-Dubois S
    Curr Opin HIV AIDS; 2019 Jul; 14(4):246-252. PubMed ID: 30994502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
    Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K
    Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression.
    Demarest JF; Jack N; Cleghorn FR; Greenberg ML; Hoffman TL; Ottinger JS; Fantry L; Edwards J; O'Brien TR; Cao K; Mahabir B; Blattner WA; Bartholomew C; Weinhold KJ
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1333-44. PubMed ID: 11602044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.
    Zhu T; Corey L; Hwangbo Y; Lee JM; Learn GH; Mullins JI; McElrath MJ
    J Virol; 2003 Jun; 77(11):6108-16. PubMed ID: 12743268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood monocytes from most human immunodeficiency virus type 1-infected patients do not carry proviral DNA.
    Shen Y; Rudnik J; Cassol S; Drouin J; Cameron W; Izaguirre CA; Filion LG
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):531-7. PubMed ID: 8556497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens.
    Perdiguero B; Gómez CE; Nájera JL; Sorzano CO; Delaloye J; González-Sanz R; Jiménez V; Roger T; Calandra T; Pantaleo G; Esteban M
    PLoS One; 2012; 7(10):e48524. PubMed ID: 23119046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of provirus-bearing CD4+ cells in HIV type 1 infection correlates with extent of in vitro apoptosis of CD8+ but not of CD4+ cells.
    Carbonari M; Cibati M; Pesce AM; Sbarigia D; Grossi P; D'Offizi G; Luzi G; Fiorilli M
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):789-94. PubMed ID: 7546905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
    Sung JA; Pickeral J; Liu L; Stanfield-Oakley SA; Lam CY; Garrido C; Pollara J; LaBranche C; Bonsignori M; Moody MA; Yang Y; Parks R; Archin N; Allard B; Kirchherr J; Kuruc JD; Gay CL; Cohen MS; Ochsenbauer C; Soderberg K; Liao HX; Montefiori D; Moore P; Johnson S; Koenig S; Haynes BF; Nordstrom JL; Margolis DM; Ferrari G
    J Clin Invest; 2015 Nov; 125(11):4077-90. PubMed ID: 26413868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response.
    Stahl-Hennig C; Steinman RM; Ten Haaft P; Uberla K; Stolte N; Saeland S; Tenner-Racz K; Racz P
    J Virol; 2002 Jan; 76(2):688-96. PubMed ID: 11752159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not Adults.
    Roider J; Maehara T; Ngoepe A; Ramsuran D; Muenchhoff M; Adland E; Aicher T; Kazer SW; Jooste P; Karim F; Kuhn W; Shalek AK; Ndung'u T; Morris L; Moore PL; Pillai S; Kløverpris H; Goulder P; Leslie A
    Front Immunol; 2018; 9():1975. PubMed ID: 30258437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
    Becker Y
    Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
    Richard J; Pacheco B; Gohain N; Veillette M; Ding S; Alsahafi N; Tolbert WD; Prévost J; Chapleau JP; Coutu M; Jia M; Brassard N; Park J; Courter JR; Melillo B; Martin L; Tremblay C; Hahn BH; Kaufmann DE; Wu X; Smith AB; Sodroski J; Pazgier M; Finzi A
    EBioMedicine; 2016 Oct; 12():208-218. PubMed ID: 27633463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.
    Duvall MG; Jaye A; Dong T; Brenchley JM; Alabi AS; Jeffries DJ; van der Sande M; Togun TO; McConkey SJ; Douek DC; McMichael AJ; Whittle HC; Koup RA; Rowland-Jones SL
    J Immunol; 2006 Jun; 176(11):6973-81. PubMed ID: 16709858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.